Get Bristol Myers Squibb alerts:BMY has been the topic of a number of other reports. Morgan Stanley reiterated a “hold” rating on shares of Bristol Myers Squibb in a research report on Thursday, July 31st. Bristol Myers Squibb has a one year low of $42.96 and a one year high of $63.33. Bristol Myers Squibb had a net margin of 10.58% and a return on equity of 80.04%. Read MoreReceive News & Ratings for Bristol Myers Squibb Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bristol Myers Squibb and related companies with MarketBeat.com's FREE daily email newsletter.